These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8525412)

  • 1. Anti-hepatitis A antibody titers after passive immunization with hepatitis A hyperimmune globulin.
    Poovorawan Y; Theamboonlers A; Vimolkej L; Cryz SJ
    Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):193-4. PubMed ID: 8525412
    [No Abstract]   [Full Text] [Related]  

  • 2. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A-vaccines: a comparison between three methods of antigen determination.
    Burkhardt F; Glück R; Finkel-Jimenez B; Brantschen S
    Dev Biol Stand; 1996; 86():129-35. PubMed ID: 8785942
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis A prevention by vaccination].
    Busch N
    Dtsch Med Wochenschr; 1998 Aug; 123(33):988. PubMed ID: 9739348
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vaccination against hepatitis A].
    Zamir D; Zamir H; Weiner P
    Harefuah; 1998 Aug; 135(3-4):114-8. PubMed ID: 9885656
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis A vaccine.
    Bader TF
    Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Sandman L; Davidson M; Krugman S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections.
    Can Commun Dis Rep; 1994 Aug; 20(16):133-43. PubMed ID: 7951129
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients.
    Stark K; Günther M; Neuhaus R; Reinke P; Schröder K; Linnig S; Bienzle U
    J Infect Dis; 1999 Dec; 180(6):2014-7. PubMed ID: 10558960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 year.
    DeFraites RF; Feighner BH; Binn LN; Kanjarpane DD; Delem AD; MacArthy PO; Krauss MR; Krause DS; Moonsammy GI; Hoke CH
    J Infect Dis; 1995 Mar; 171 Suppl 1():S61-9. PubMed ID: 7876651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell mediated and antibody immune response to inactivated hepatitis A vaccine.
    Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F
    Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on re-immunization with live attenuated hepatitis A vaccine].
    Liu Y; Xu Z; Ouyang P
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):162-4. PubMed ID: 10322791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermostability of an inactivated hepatitis A vaccine stored at 37 degrees C for one week.
    Wiedermann G; Ambrosch F; André FE; Delem A; D'Hondt E; Safary A
    J Med Virol; 1994 Dec; 44(4):442. PubMed ID: 7897377
    [No Abstract]   [Full Text] [Related]  

  • 17. Host immune response to hepatitis A virus.
    Stapleton JT
    J Infect Dis; 1995 Mar; 171 Suppl 1():S9-14. PubMed ID: 7876654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
    Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
    Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of vaccine-induced antibody to hepatitis A virus.
    Wiedermann G; Ambrosch F; André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S129-31. PubMed ID: 1335643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.